Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-04-28FDA Approved: ETODOLAC — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Etodolac submitted by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2021-04-28FDA Approved: MECLOFENAMATE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for meclofenamate sodium from Mylan Pharmaceuticals Inc.
-
FDA approval · 2021-04-28FDA Approved: ETODOLAC — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for etodolac from Amneal Pharmaceuticals NY LLC under ANDA 208834.
-
FDA approval · 2021-04-28FDA Approved: ETODOLAC — Supplemental Application (Chartwell RX, LLC)
The FDA has approved a supplemental application for etodolac submitted by Chartwell RX, LLC.
-
FDA approval · 2021-04-28FDA Approved: RELAFEN DS — Supplemental Application (Carwin Pharmaceutical Associates, LLC)
FDA approved a supplemental application for Relafen DS (nabumetone) submitted by Carwin Pharmaceutical Associates, LLC. Nabumetone is used t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-04-28FDA Approved: NABUMETONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Nabumetone submitted by Actavis Pharma, Inc., relating to Nabumetone's approval status.
-
FDA approval · 2021-04-28FDA Approved: IBUPROFEN — Supplemental Application (Major Pharmaceuticals)
The FDA approved Major Pharmaceuticals' ibuprofen supplemental application, finalizing regulatory changes for this product under an ANDA pro…
-
FDA approval · 2021-04-28FDA Approved: NABUMETONE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for Nabumetone from Exelan Pharmaceuticals Inc. to modify an aspect of the approved product. This ac…
-
FDA approval · 2021-04-28FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
The FDA approved a supplemental application for Tolmetin Sodium from Atland Pharmaceuticals, LLC, updating an existing approval.
-
FDA approval · 2021-04-26FDA Approved: DICLOFENAC POTASSIUM — Supplemental Application (Trifluent Pharma LLC)
FDA approved a supplemental application for Diclofenac potassium from Trifluent Pharma LLC as a generic product.
-
FDA approval · 2021-04-26FDA Approved: INDOMETHACIN — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Indomethacin submitted by XLCare Pharmaceuticals Inc. under ANDA 091240.
-
FDA approval · 2021-04-26FDA Approved: ETODOLAC — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Etodolac from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2021-03-31FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Diclofenac Sodium from Actavis Pharma, Inc. under ANDA074514. The approval covers an updated for…
-
FDA approval · 2021-03-29FDA Approved: LEFLUNOMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved an original-application generic for Leflunomide from Aurobindo Pharma Limited.
-
FDA approval · 2021-03-26FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' supplemental application for diclofenac sodium (a generic NSAID).
-
FDA approval · 2021-02-24FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approval of a supplemental application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc.
-
FDA approval · 2021-01-15FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for AZULFIDINE EN-TABS (sulfasalazine) from Pfizer, resulting in updated labeling and/or approved in…
-
FDA approval · 2021-01-07FDA Approved: AZATHIOPRINE SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for azathioprine sodium from Hikma Pharmaceuticals USA Inc., updating the generic product's approval…
-
FDA approval · 2020-12-17FDA Approved: RIABNI — Original Application (Amgen, Inc)
FDA approved RIABNI (rituximab-arrx) from Amgen as a biosimilar to rituximab via Original Application.
-
FDA approval · 2020-12-16FDA Approved: ETODOLAC — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved the original ANDA for etodolac from Unichem Pharmaceuticals (USA), Inc., a generic NSAID. It is indicated for relief of sig…
-
FDA approval · 2020-12-12FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., resulting in changes to the product labeling. This act…
-
FDA approval · 2020-12-03FDA Approved: CELECOXIB — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved the original ANDA for Celecoxib from ScieGen Pharmaceuticals, a generic version of the COX-2 inhibitor used for pain relief. It…
-
FDA approval · 2020-10-28FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps (naproxen sodium) as a new gelcap dosage form for naproxen sodium, expanding th…
-
FDA approval · 2020-09-25FDA Approved: XELJANZ — Original Application (Pfizer Laboratories Div Pfizer Inc)
This FDA entry documents the original approval of XELJANZ (tofacitinib) by Pfizer for rheumatoid arthritis.
-
FDA approval · 2020-09-24FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for the diclofenac sodium and misoprostol product from Mylan Pharmaceuticals, updating its label…